Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T12:49:01.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T17:35:55.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software release.
    Difference
    0.0%
    Check dated 2025-09-28T11:13:02.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:42:24.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T21:27:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Pembrolizumab, Cisplatin, and Fluorouracil, as well as recent research articles related to stomach cancer. Additionally, the facility name and location have been added, while some previous location details and cancer-related terms have been removed.
    Difference
    7%
    Check dated 2025-08-30T16:03:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.